1-3 of 3
Luke Whitesell
Close
Sort by
Journal Articles

Inhibition of Translation Initiation and Heat Shock Factor 1 (HSF1): A Novel Strategy Targeting FLT3 Double Mutant and Non-FLT3 Mutant AML Progenitor/Stem Cells

Jo Ishizawa, MD PhD, Ran Zhao, Lauren Heese, Alex Jaeger, PhD, Yuki Nishida, Rodrigo Jacamo, PhD, Kensuke Kojima, MD PhD, Man Chun John MA, PhD, Vivian Ruvolo, PhD, Dhruv Chachad, R. Eric Davis, MD, William Devine, PhD, John A Porco, Jr., PhD, Luke Whitesell, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2637.
https://doi.org/10.1182/blood.V130.Suppl_1.2637.2637
Published: 2017
Journal Articles

Inactivating Heat Shock Factor 1 (HSF1) in Acute Myeloid Leukemia By Pharmacological Inhibition of eIF4a: A Promising Therapeutic Approach

Jo Ishizawa, MD PhD, Rodrigo Omar Jacamo, PhD, Kensuke Kojima, MD PhD, Dhruv Chachad, MS, Vivian Ruvolo, MS, Peter Ruvolo, PhD, Weiguo Zang, PhD, Yoko Tabe, MD PhD, Marina Konopleva, MD PhD, William Devine, PhD, Susan Lindquist, PhD, John A Porco, Jr., Luke Whitesell, MD PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2548.
https://doi.org/10.1182/blood.V126.23.2548.2548
Published: 2015
Journal Articles

Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity

Hanping Feng, Yi Zeng, Luke Whitesell, Emmanuel Katsanis
Journal: Blood
Blood (2001) 97 (11): 3505–3512.
https://doi.org/10.1182/blood.V97.11.3505
Published: 2001